A daily low dose of aspirin reduced the risk of colon and rectal cancer recurrence by more than half in certain patients, according to results from a large clinical trial led by Karolinska Institutet and Karolinska University Hospital. The study, confirming that Aspirin Reduces Colon Cancer recurrence in genetically defined patients, was published Sept. 17 in The New England Journal o... http://thelifesciencesmagazine.com/aspirin-reduces-colon-cancer-risk/